1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with atrial natriuretic factor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amuzie, C; Avolio, A; Bedja, D; Chatterjee, S; Mishra, S | 1 |
1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and atrial natriuretic factor
Article | Year |
---|---|
Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-/- mice.
Topics: Animals; Apolipoproteins E; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cholesterol; Diet, High-Fat; Enzyme Inhibitors; Galactosyltransferases; Gene Expression; Glucosyltransferases; Glycosphingolipids; Heart Ventricles; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Morpholines; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation | 2015 |